News
A study following Scottish international rugby players shows they are more likely to develop neurodegenerative conditions compared to the general public.
Jeremy Paxman has opened up about his experience of living with Parkinson's.
A project involving Parkinson's UK, shows promise for using artificial intelligence to identify Parkinson's in brains donated to our Brain Bank.
Results from a US study show that a hormone called irisin has the potential to halt the progression of Parkinson's in mice.
Scientists at the University of Manchester have developed a test which could help diagnose Parkinson's in 3 minutes using a simple skin swab.
The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
Over the next 3 years, the US-based Parkinson's Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson's Virtual Biotech, our international drug discovery and development programme.
2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson's.
We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.